These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Judicious evaluation of adverse drug reactions: inaccurate assessment of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced muscle injury. Dietz BL; Oberg KC Pharmacotherapy; 1999 Feb; 19(2):232-5. PubMed ID: 10030775 [TBL] [Abstract][Full Text] [Related]
25. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats. Abdelbaset M; Safar MM; Mahmoud SS; Negm SA; Agha AM Can J Physiol Pharmacol; 2014 Jun; 92(6):481-9. PubMed ID: 24896301 [TBL] [Abstract][Full Text] [Related]
26. Discontinuation of statin therapy due to muscular side effects: a survey in real life. Rosenbaum D; Dallongeville J; Sabouret P; Bruckert E Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):871-5. PubMed ID: 22748604 [TBL] [Abstract][Full Text] [Related]
27. Letter by Rosenberg and Uretsky regarding article, "Risks associated with statin therapy: a systematic overview of randomized clinical trials". Rosenberg L; Uretsky S Circulation; 2007 Jul; 116(1):e8; author reply e9. PubMed ID: 17606852 [No Abstract] [Full Text] [Related]
28. [A case of interstitial lung disease with atorvastatin (Tahor) and a review of the literature about these effects observed under statins]. Veyrac G; Cellerin L; Jolliet P Therapie; 2006; 61(1):57-67. PubMed ID: 16792155 [TBL] [Abstract][Full Text] [Related]